Approximately one-third of AML patients carry constitutive activating mutations in the FLT3 gene, mostly internal tandem duplication (ITD), which are in-frame duplications of nucleotide sequences with different lengths and insertion sites [4]. Here, FLT3 is linked to acute myeloid leukemia.